Project
SOS AMI Selatogrel
Ongoing - recruitment active ยท 2022 until 2026
Maeder Micha, Vetsch Susanne, Fink Karin
Type
Range
Units
Status
Start Date
End Date
Financing
Study Design
Brief description/objective
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction